{"id":"https://openalex.org/W2000302463","doi":"https://doi.org/10.1038/sj.bjp.0705089","title":"Identification of the di\u2010pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti\u2010tumour agents","display_name":"Identification of the di\u2010pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti\u2010tumour agents","alternate_titles":[],"publication_year":2003,"publication_date":"2003-03-01","ids":{"openalex":"https://openalex.org/W2000302463","doi":"https://doi.org/10.1038/sj.bjp.0705089","mag":"2000302463","pmid":"https://pubmed.ncbi.nlm.nih.gov/12642383","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1573713"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjp.0705089","doi":"https://doi.org/10.1038/sj.bjp.0705089","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0705089","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705089","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000302463"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705089","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108449199","display_name":"E. Becker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Erika M Becker","raw_affiliation_strings":["The Department of Medicine, University of Queensland, Royal Brisbane Hospital, Herston, Brisbane, Queensland 4029, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Department of Medicine, University of Queensland, Royal Brisbane Hospital, Herston, Brisbane, Queensland 4029, Australia","institution_ids":["https://openalex.org/I165143802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055735150","display_name":"David B. Lovejoy","orcid":"https://orcid.org/0000-0002-5331-8659","observed_orcids":["https://orcid.org/0000-0002-5331-8659"]},"institutions":[{"id":"https://openalex.org/I2801241159","display_name":"The Heart Research Institute","ror":"https://ror.org/046fa4y88","country_code":"AU","type":"facility","lineage":["https://openalex.org/I2801241159"]},{"id":"https://openalex.org/I4210112315","display_name":"Children's Cancer Institute Australia","ror":"https://ror.org/01x784220","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210112315"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David B Lovejoy","raw_affiliation_strings":["Children's Cancer Institute Australia for Medical Research, Iron Metabolism and Chelation Program, PO Box 81, High Street, Sydney, New South Wales, 2031 Australia","The Heart Research Institute, Iron Metabolism and Chelation Group, 145 Missenden Road, Sydney, New South Wales, 2050 Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Institute Australia for Medical Research, Iron Metabolism and Chelation Program, PO Box 81, High Street, Sydney, New South Wales, 2031 Australia","institution_ids":["https://openalex.org/I4210112315"]},{"raw_affiliation_string":"The Heart Research Institute, Iron Metabolism and Chelation Group, 145 Missenden Road, Sydney, New South Wales, 2050 Australia","institution_ids":["https://openalex.org/I2801241159"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052740642","display_name":"Judith M. Greer","orcid":"https://orcid.org/0000-0003-4440-4309","observed_orcids":["https://orcid.org/0000-0003-4440-4309"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Judith M Greer","raw_affiliation_strings":["The Department of Medicine, University of Queensland, Royal Brisbane Hospital, Herston, Brisbane, Queensland 4029, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Department of Medicine, University of Queensland, Royal Brisbane Hospital, Herston, Brisbane, Queensland 4029, Australia","institution_ids":["https://openalex.org/I165143802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089917423","display_name":"Ralph Watts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801241159","display_name":"The Heart Research Institute","ror":"https://ror.org/046fa4y88","country_code":"AU","type":"facility","lineage":["https://openalex.org/I2801241159"]},{"id":"https://openalex.org/I4210112315","display_name":"Children's Cancer Institute Australia","ror":"https://ror.org/01x784220","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210112315"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ralph Watts","raw_affiliation_strings":["Children's Cancer Institute Australia for Medical Research, Iron Metabolism and Chelation Program, PO Box 81, High Street, Sydney, New South Wales, 2031 Australia","The Heart Research Institute, Iron Metabolism and Chelation Group, 145 Missenden Road, Sydney, New South Wales, 2050 Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Institute Australia for Medical Research, Iron Metabolism and Chelation Program, PO Box 81, High Street, Sydney, New South Wales, 2031 Australia","institution_ids":["https://openalex.org/I4210112315"]},{"raw_affiliation_string":"The Heart Research Institute, Iron Metabolism and Chelation Group, 145 Missenden Road, Sydney, New South Wales, 2050 Australia","institution_ids":["https://openalex.org/I2801241159"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061763563","display_name":"Des Raymond Richardson","orcid":"https://orcid.org/0000-0002-5506-3274","observed_orcids":["https://orcid.org/0000-0002-5506-3274","https://orcid.org/0000-0003-0960-6415"]},"institutions":[{"id":"https://openalex.org/I2801241159","display_name":"The Heart Research Institute","ror":"https://ror.org/046fa4y88","country_code":"AU","type":"facility","lineage":["https://openalex.org/I2801241159"]},{"id":"https://openalex.org/I4210112315","display_name":"Children's Cancer Institute Australia","ror":"https://ror.org/01x784220","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210112315"]}],"countries":["AU"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Des R Richardson","raw_affiliation_strings":["Children's Cancer Institute Australia for Medical Research, Iron Metabolism and Chelation Program, PO Box 81, High Street, Sydney, New South Wales, 2031 Australia","The Heart Research Institute, Iron Metabolism and Chelation Group, 145 Missenden Road, Sydney, New South Wales, 2050 Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Institute Australia for Medical Research, Iron Metabolism and Chelation Program, PO Box 81, High Street, Sydney, New South Wales, 2031 Australia","institution_ids":["https://openalex.org/I4210112315"]},{"raw_affiliation_string":"The Heart Research Institute, Iron Metabolism and Chelation Group, 145 Missenden Road, Sydney, New South Wales, 2050 Australia","institution_ids":["https://openalex.org/I2801241159"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5061763563"],"corresponding_institution_ids":["https://openalex.org/I2801241159","https://openalex.org/I4210112315"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":2.9009,"has_fulltext":true,"cited_by_count":109,"citation_normalized_percentile":{"value":0.9060891,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"138","issue":"5","first_page":"819","last_page":"830"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.37059998512268066,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.37059998512268066,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.30489999055862427,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":0.2078000009059906,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/iron-chelators","display_name":"iron chelators","score":0.9070000052452087},{"id":"https://openalex.org/keywords/isonicotinoylhydrazones","display_name":"isonicotinoylhydrazones","score":0.8849999904632568},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.9350000023841858},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.8980000019073486},{"id":"https://openalex.org/keywords/dna-synthesis-inhibition","display_name":"DNA synthesis inhibition","score":0.9259999990463257},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.8550000190734863},{"id":"https://openalex.org/keywords/iron-absorption","display_name":"iron absorption","score":0.6700000166893005},{"id":"https://openalex.org/keywords/iron-efflux","display_name":"iron efflux","score":0.8009999990463257},{"id":"https://openalex.org/keywords/iron-regulatory-proteins","display_name":"iron regulatory proteins","score":0.8180000185966492},{"id":"https://openalex.org/keywords/lipophilicity","display_name":"lipophilicity","score":0.8270000219345093},{"id":"https://openalex.org/keywords/membrane-permeability","display_name":"membrane permeability","score":0.9369999766349792},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.6909999847412109}],"concepts":[{"id":"https://openalex.org/C2780349576","wikidata":"https://www.wikidata.org/wiki/Q416007","display_name":"Hydrazone","level":2,"score":0.8506425619125366},{"id":"https://openalex.org/C201399114","wikidata":"https://www.wikidata.org/wiki/Q898401","display_name":"Lipophilicity","level":2,"score":0.8351703882217407},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8029764890670776},{"id":"https://openalex.org/C197404232","wikidata":"https://www.wikidata.org/wiki/Q319827","display_name":"Chelation","level":2,"score":0.7121034860610962},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5865036249160767},{"id":"https://openalex.org/C2776568683","wikidata":"https://www.wikidata.org/wiki/Q23005640","display_name":"Moiety","level":2,"score":0.5438966155052185},{"id":"https://openalex.org/C2992270614","wikidata":"https://www.wikidata.org/wiki/Q29548","display_name":"Membrane permeability","level":3,"score":0.4538014531135559},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.4372618794441223},{"id":"https://openalex.org/C2777738585","wikidata":"https://www.wikidata.org/wiki/Q170744","display_name":"Ketone","level":2,"score":0.42403650283813477},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3583090007305145},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3429988622665405},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.33414310216903687},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.21160846948623657},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.1300317943096161}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006835","descriptor_name":"Hydrazones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006835","descriptor_name":"Hydrazones","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D007502","descriptor_name":"Iron Chelating Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007502","descriptor_name":"Iron Chelating Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1038/sj.bjp.0705089","doi":"https://doi.org/10.1038/sj.bjp.0705089","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0705089","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705089","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1573713","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1573713/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},{"id":"pmid:12642383","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12642383","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.1038/sj.bjp.0705089","doi":"https://doi.org/10.1038/sj.bjp.0705089","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0705089","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705089","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.5683000087738037,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2000302463.pdf","grobid_xml":"https://content.openalex.org/works/W2000302463.grobid-xml"},"referenced_works_count":67,"referenced_works":["https://openalex.org/W34816746","https://openalex.org/W116663061","https://openalex.org/W169275994","https://openalex.org/W244409642","https://openalex.org/W334184796","https://openalex.org/W1497514444","https://openalex.org/W1502461041","https://openalex.org/W1508340483","https://openalex.org/W1514932744","https://openalex.org/W1535189264","https://openalex.org/W1536598476","https://openalex.org/W1547848353","https://openalex.org/W1550693195","https://openalex.org/W1564880933","https://openalex.org/W1603151752","https://openalex.org/W1647656396","https://openalex.org/W1649488331","https://openalex.org/W1871616831","https://openalex.org/W1894026278","https://openalex.org/W1965780768","https://openalex.org/W1970518172","https://openalex.org/W1970929549","https://openalex.org/W1971437863","https://openalex.org/W1986179131","https://openalex.org/W1992125101","https://openalex.org/W1993455564","https://openalex.org/W1994166804","https://openalex.org/W1996920684","https://openalex.org/W2006277511","https://openalex.org/W2008596858","https://openalex.org/W2015519364","https://openalex.org/W2017350478","https://openalex.org/W2019227458","https://openalex.org/W2022288325","https://openalex.org/W2031773431","https://openalex.org/W2035763080","https://openalex.org/W2048312836","https://openalex.org/W2051983330","https://openalex.org/W2055017899","https://openalex.org/W2062338388","https://openalex.org/W2062464829","https://openalex.org/W2063617352","https://openalex.org/W2065071495","https://openalex.org/W2068675344","https://openalex.org/W2077486603","https://openalex.org/W2080711791","https://openalex.org/W2081330846","https://openalex.org/W2082163465","https://openalex.org/W2099819774","https://openalex.org/W2104434601","https://openalex.org/W2110508537","https://openalex.org/W2119272726","https://openalex.org/W2146449631","https://openalex.org/W2159401034","https://openalex.org/W2160225986","https://openalex.org/W2162714305","https://openalex.org/W2164601045","https://openalex.org/W2178778111","https://openalex.org/W2324563126","https://openalex.org/W2339869834","https://openalex.org/W2400973399","https://openalex.org/W2401833113","https://openalex.org/W2409616927","https://openalex.org/W2411088972","https://openalex.org/W2417365885","https://openalex.org/W2465921122","https://openalex.org/W2466152945"],"related_works":["https://openalex.org/W2081703161","https://openalex.org/W2065071495","https://openalex.org/W2087963699","https://openalex.org/W1502461041","https://openalex.org/W2073819841","https://openalex.org/W34816746","https://openalex.org/W116663061","https://openalex.org/W7009298523","https://openalex.org/W2089027621","https://openalex.org/W2025177304"],"abstract_inverted_index":{"(1)":[0],"In":[1,147,184,210],"an":[2],"attempt":[3],"to":[4,73,166,186],"develop":[5],"chelators":[6,222,239],"as":[7,136],"potent":[8,237],"anti-tumour":[9],"agents,":[10],"we":[11,91],"synthesized":[12],"two":[13],"series":[14],"of":[15,44,70,103,122,142,163,193,202,221,233,242],"novel":[16,231],"ligands":[17,75,125,165,234],"based":[18,76],"on":[19,77,95],"the":[20,41,45,53,67,101,119,123,127,132,137,149,161,179,187,194,199,219],"very":[21],"active":[22],"2-pyridylcarboxaldehyde":[23],"isonicotinoyl":[24,79,84],"hydrazone":[25,80,85],"(PCIH)":[26],"group.":[27],"Since":[28],"lipophilicity":[29,121],"and":[30,82,111,114,126,156,169,189,240,245],"membrane":[31],"permeability":[32],"play":[33],"a":[34,230],"critical":[35],"role":[36],"in":[37,218],"Fe":[38,97,99,157,238],"chelation":[39,158],"efficacy,":[40,90],"aldehyde":[42],"moiety":[43],"PCIH":[46,138,188],"series,":[47,139],"namely":[48],"2-pyridylcarboxaldehyde,":[49],"was":[50,172],"replaced":[51],"with":[52,66,223],"more":[54],"lipophilic":[55],"2-quinolinecarboxaldehyde":[56,78],"or":[57,174],"di-2-pyridylketone":[58,83],"moieties.":[59],"These":[60],"compounds":[61,144],"were":[62,145],"then":[63],"systematically":[64],"condensed":[65],"same":[68,133],"group":[69,196],"acid":[71],"hydrazides":[72],"yield":[74],"(QCIH)":[81],"(PKIH).":[86],"To":[87],"examine":[88],"chelator":[89],"assessed":[92],"their":[93],"effects":[94],"proliferation,":[96],"uptake,":[98],"efflux,":[100],"expression":[102],"cell":[104,206],"cycle":[105,207],"control":[106],"molecules,":[107],"iron-regulatory":[108],"protein-RNA-binding":[109],"activity,":[110],"(3)H-thymidine,":[112],"(3)H-uridine":[113],"(3)H-leucine":[115],"incorporation.":[116],"(2)":[117],"Despite":[118],"high":[120,224],"QCIH":[124,190],"fact":[128],"that":[129,176,235],"they":[130],"have":[131,228],"Fe-binding":[134],"site":[135],"surprisingly":[140],"none":[141],"these":[143,164],"effective.":[146],"contrast,":[148],"PKIH":[150,195],"analogues":[151],"showed":[152],"marked":[153],"anti-proliferative":[154,225],"activity":[155],"efficacy.":[159],"Indeed,":[160],"ability":[162],"inhibit":[167],"proliferation":[168],"DNA":[170,243],"synthesis":[171],"similar":[173],"exceeded":[175],"found":[177],"for":[178,205],"highly":[180],"cytotoxic":[181],"chelator,":[182],"311.":[183],"contrast":[185],"analogues,":[191],"most":[192],"markedly":[197],"increased":[198],"mRNA":[200],"levels":[201],"molecules":[203],"vital":[204],"arrest.":[208],"(3)":[209],"conclusion,":[211],"our":[212],"studies":[213],"identify":[214],"structural":[215],"features":[216],"useful":[217],"design":[220],"activity.":[226],"We":[227],"identified":[229],"class":[232],"are":[236],"inhibitors":[241],"synthesis,":[244],"which":[246],"deserve":[247],"further":[248],"investigation.":[249]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000302463","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":15},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
